Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis
Conclusions: Oxaliplatin-based regimen is superior to cisplatin-based regimen in tumour remission as first-line chemotherapy for advanced GC, and is associated with less toxicity and better tolerability.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Fei Zhang, Yiyin Zhang, Zhenya Jia, Hongyang Wu, Kangsheng Gu Tags: Research Paper Source Type: research
More News: Anemia | Brain | Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Liver | Neurology | Study | Thrombocytopenia | Thrombosis | Toxicology | Urology & Nephrology